401EP, Principal Scientist / Senior Scientist, Cancer Immunotherapy

Job Code 401EP

Description

Fate Therapeutics is seeking a highly motivated Immunologist with expertise in immune oncology to join a multidisciplinary team dedicated to the discovery of novel cellular therapeutics. The candidate must have in-depth knowledge of NK or T cell biology, with a focus on cell-based therapy and solid tumors. Extensive experience with in vitro functional characterization of NK or T cells is required. Experience with in vivo cell-derived xenograft, patient-derived xenograft, and/or syngeneic tumor models is highly desired. As a leader in our cancer immunotherapy team, the successful candidate will provide scientific and technical input for ongoing project initiatives in addition to executing and overseeing key in vitro and in vivo studies. Previous industry experience preferred. This is a full-time position reporting to an Associate Director, Cancer Immunotherapy and is located at the Company’s corporate headquarters in San Diego, California.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 401EP.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.